Department of Cardiology, Saint Vincent de Paul Hospital, Gdynia, Poland
Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdańsk, Poland
Kardiol Pol. 2021 Mar 25;79(3):302-310. doi: 10.33963/KP.15763. Epub 2021 Jan 19.
Patients hospitalized for heart failure (HF) exacerbation tend to have a poor prognosis. Most previous studies were performed in large clinical centers and detailed analyses of patients with HF hospitalized in district general hospitals are lacking.
The aim of this study was to assess the outcomes of patients admitted with HF exacerbation to a district general hospital.
We retrospectively enrolled patients hospitalized for HF exacerbation in the years 2010 to 2011 (191 patients) and 2016 to 2017 (203 patients). The primary and secondary endpoints were all‑cause mortality and rehospitalization due to HF exacerbation, respectively, within a 2‑year follow‑up.
Compared with patients hospitalized from 2010 to 2011, those hospitalized from 2016 to 2017 had more favorable clinical parameters and more appropriate pharmacological treatment; however, the rate of implantable cardioverter‑defibrillator and resynchronization device use remained low. The overall mortality decreased from 44% between 2010 and 2011 to 33% between 2016 and 2017 (P = 0.03), but the number of rehospitalizations increased from 26% to 41%, respectively (P <0.001). Male sex, low systolic blood pressure, symptoms of right HF, and renal dysfunction were independent risk factors for the primary endpoint. Symptoms of right HF, renal dysfunction, left ventricular ejection fraction below 24%, and low systolic blood pressure independently predicted the secondary endpoint.
The prognosis of patients hospitalized for decompensated HF in a regional district hospital was poor. Despite some improvement in pharmacological treatment, which probably led to reduced all‑‑cause mortality, there was a low rate of implantable electronic device use and a high rate of rehospitalizations due to HF exacerbation, which needs further elucidation.
心力衰竭(HF)恶化住院的患者往往预后不良。大多数先前的研究都是在大型临床中心进行的,缺乏对地区综合医院住院 HF 患者的详细分析。
本研究旨在评估因 HF 恶化而住院的患者的结局。
我们回顾性纳入了 2010 年至 2011 年(191 例患者)和 2016 年至 2017 年(203 例患者)期间因 HF 恶化住院的患者。主要和次要终点分别为 2 年随访期间的全因死亡率和因 HF 恶化再住院率。
与 2010 年至 2011 年住院的患者相比,2016 年至 2017 年住院的患者具有更有利的临床参数和更适当的药物治疗;然而,植入式心脏复律除颤器和再同步装置的使用率仍然较低。总死亡率从 2010 年至 2011 年的 44%降至 2016 年至 2017 年的 33%(P = 0.03),但再住院率分别从 26%增至 41%(P <0.001)。男性、低收缩压、右心衰竭症状和肾功能不全是主要终点的独立危险因素。右心衰竭症状、肾功能不全、左心室射血分数低于 24%和低收缩压独立预测次要终点。
地区综合医院因失代偿性 HF 住院的患者预后较差。尽管药物治疗有所改善,可能导致全因死亡率降低,但植入式电子设备使用率较低,HF 恶化再住院率较高,需要进一步阐明。